GLP-1 Medications Show Promise for Improving HS Symptoms February 23, 2026 Authors: Allison Hanka, College of Biological Sciences, University of Minnesota, Minneapolis, MN Jordyn Nepper, BS, Department of Dermatology, University of Minnesota, Minneapolis, MN Noah Goldfarb, MD, Associate Professor, Departments of Medicine and Dermatology, University of Minnesota, Minneapolis, MN Why was this research done
Insights into the structure, function, and ligand discovery of the large neutral amino acid transporter 1, LAT1
Unlike older medical treatments that required mixing or measuring, the Wegovy Pen is a pre-filled, single-dose injector designed for safety and simplicity
That documented, patient-specific pathway is what remained lawful after the FDA spent 2025 shutting down the mass-market compounded copycats